Search

Search results

280 results found

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Venous Thromboembolism: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Chiang, Cho-Han, Yu-Cheng Chang, Chun-Chiao Yu, Xin Ya See, Tsu Hsien Wang, Nutchapon Xanthavanij, Junmin Song, et al. 2025. “Glucagon-Like Peptide 1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.”. Journal of Thrombosis and Haemostasis : JTH.

Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure.

Anderson, Emily, Yun Choi, Rachel J Buchsbaum, Andreas Klein, Bonnie Ky, Daniel Landsburg, Urshila Durani, et al. 2025. “Hematology-Oncology Provider Perspectives Regarding Lymphoma Treatment and Cardioprotective Strategies in Patients With Lymphoma at High Risk for Heart Failure.”. Leukemia & Lymphoma, 1-10.

Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries.

Dangas, Katerina, Joseph M Kim, Siling Li, Yang Song, Andrew S Oseran, Robert W Yeh, Rishi K Wadhera, and Eric A Secemsky. 2025. “Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries.”. Circulation. Cardiovascular Quality and Outcomes 18 (10): e012099.